Bracigliano, Italy

Anna Basile

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Fibrosys S.r.l.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Basile. Retrieved from https://idiyas.com/inventor/anna-basile

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anna Basile: Innovator in Cardiovascular Therapeutics

Introduction

Anna Basile is a prominent inventor based in Bracigliano, Italy. She has made significant contributions to the field of cardiovascular medicine through her innovative research and development of therapeutic agents. Her work focuses on the use of anti-BAG3 antibodies, which have the potential to revolutionize treatment options for cardiovascular diseases.

Latest Patents

Anna Basile holds a patent for "Anti-BAG3 antibodies as therapeutic reagent in cardiovascular disease." This invention relates to the use of anti-BAG3 antibodies and their pharmaceutical formulation in the treatment of cardiovascular diseases. This patent highlights her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Anna has demonstrated exceptional expertise in her field. She has been instrumental in the development of innovative therapies that address critical health challenges. Her dedication to research and innovation has positioned her as a leader in the medical community.

Collaborations

Anna collaborates with talented professionals, including Maria Caterina Turco and Liberato Marzullo. These partnerships enhance her research efforts and contribute to the advancement of therapeutic solutions in cardiovascular health.

Conclusion

Anna Basile's work exemplifies the impact of innovation in medicine. Her contributions to the development of anti-BAG3 antibodies represent a significant step forward in the treatment of cardiovascular diseases. Through her research and collaborations, she continues to inspire advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…